- Home
- GASS vs FHTX Comparison
GASS vs FHTX Comparison
Compare GASS & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GASS | FHTX |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.4M | 323.4M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GASS | FHTX |
|---|---|---|
| Price | $9.85 | $4.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 107.5K | ★ 121.3K |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,909,000.00 |
| Revenue This Year | N/A | $8.89 |
| Revenue Next Year | N/A | $20.13 |
| P/E Ratio | $5.00 | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $5.38 | $3.27 |
| 52 Week High | $10.55 | $6.95 |
Technical Indicators
Market Signals| Indicator | GASS | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 44.98 |
| Support Level | $8.66 | $3.65 |
| Resistance Level | $10.49 | $5.82 |
| Average True Range (ATR) | 0.31 | 0.27 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 24.39 | 49.80 |
Price Performance
Historical ComparisonAbout GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.